BMS Sees Mixed Results in 2023: Growth in New Products Offset by Loss of Exclusivity
Bristol Myers Squibb (BMS; NYSE: BMY) reported a 2% year-on-year contraction in 2023 revenues, excluding...
Finance
Matridx Bio Secures Series C+ Funding to Advance Infectious Pathogens Diagnostics
Hangzhou Matridx Biotechnology Co., Ltd, a specialist in molecular diagnostics for infectious pathogens based in...
Roche Posts Modest 2023 Growth Amid Shifts in Demand for COVID-Related Products
Swiss pharmaceutical giant Roche (SWX: ROG) has published its 2023 financial results, showing a modest...
Takeda Reports Flat 9-Month Revenue Growth Amid Pipeline Optimization Efforts
Takeda (TYO: 4502), a leading Japanese pharmaceutical company, has released its financial results for the...
Rebecca Tech Secures USD 10 Million in Series A++ Funding to Expand Micro RF Technology Globally
Rebecca Tech LLC, a Hangzhou-based manufacturer specializing in microelectromechanical RF (radiofrequency) technology, has announced the...
GSK Posts 5% YOY Growth in 2023 Financials, Vaccines Business Drives Expansion
GSK plc (NYSE: GSK), the UK pharmaceutical giant, announced its financial results for the fourth...
Novartis Sees Robust Growth in Innovative Medicines with 2023 Financials Reflecting a Shift Toward R&D Focus
Novartis (NYSE: NVS), the Swiss pharmaceutical giant, reported a substantial leap in its global sales...
Shanghai CureGene Pharmaceutical Secures USD 14 Million in Series B Financing to Advance Cardiovascular Treatments
Shanghai CureGene Pharmaceutical Co., Ltd, a Chinese biopharmaceutical company, has announced the successful completion of...
Blue Sail Medical Secures RMB 900 Million Investment for R&D and Capacity Expansion
Blue Sail Medical Co., Ltd (SHE: 002382) has announced that its wholly owned subsidiary, Blue...
Mindray to Acquire 21.12% Stake in APT Medical for RMB 6.652 Billion
Mindray (SHE: 300760), a leading China-based medtech firm, has announced plans to acquire a 21.12%...
BJ Bioscience Inc. Faces Bankruptcy as Hangzhou Court Accepts Liquidation Application
The Hangzhou Yuhang District People’s Court has released a document indicating that BJ Bioscience Inc.’s...
Shanghai’s Reunion Biotech Secures Series B Funding to Advance Hydrogel Products
Reunion Biotech, a Shanghai-based medical hydrogel manufacturer, has reportedly secured nearly RMB 100 million (USD...
Digital Precision Medicine Secures Over $28 Million in Series C Financing
Digital Precision Medicine (DPM), a molecular imaging technology developer incubated by the Chinese Academy of...
Endoso Life Raises Over $14 Million in Series A to Expand Endoscope Product Lines
Endoso Life, a developer of high-end medical endoscope systems headquartered in Hangzhou, has reportedly secured...
Bayer Unveils New Operating Model to Drive Profitable Growth Amid Challenges
Facing a challenging business landscape, Germany’s Bayer (ETR: BAYN) has announced a new operating model...
Shanghai’s EnjoSim Secures Tens of Millions in Pre-Series A Funding for Expansion
EnjoSim, a Shanghai-based developer of microbiologic self-administration systems, has reportedly secured tens of millions of...
Changchun High & New Technology to Transfer 7.42% Stake to Ex-Wife in Divorce Settlement
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has announced plans to transfer...
Keylights Biotechnology Raises $14 Million in Series B to Expand IVD Instrument Range
Keylights Biotechnology Co., Ltd., a leading in vitro diagnostic (IVD) instruments manufacturer headquartered in Shenzhen,...
C4 Therapeutics Outlines 2024 Focus Amid 30% Workforce Reduction, Prioritizes Key Oncology Trials
C4 Therapeutics (NASDAQ: CCCC), a leader in protein degradation, announced this week its strategic focus...
Synvida Raises Nearly RMB 200 Million in Series A Funding to Advance Clinical Studies
Synvida, a biotech company incubated by Shanghai Pharma (HKG: 2607, SHA: 601607) and Shanghai Healthcare...